Ellen MacArthur Cancer Trust and Musto extend partnership

The Ellen MacArthur Cancer Trust (EMCT) will celebrate 20 years of support from Musto after agreeing to extend their long-standing partnership to the end of 2025.

Musto has been the official clothing suppliers since the EMCT was launched in 2003, having kitted out Dame Ellen MacArthur during her round the world sailing career.

Through sailing and outdoor activity, the EMCT inspires young people aged 8-24 to believe in a brighter future living through and beyond cancer. 

Each year Musto supplies young people, volunteers and skippers on the EMCT’s trips with essential sailing and sun-protective gear, including UPF 50 long-sleeved t-shirts, caps, waterproofs and salopettes. The sun protection is of particular importance as skin cancer is a common secondary cancer in young people who have had treatments such as radiation or chemotherapy.

“Musto are a partner in the truest sense of the word; at every major point in our history Musto have been with us,” says MacArthur. “From supporting just five young people on our first trip to an incredible 650 in 2019; to our expansion from sailing to running outdoor activity and canal trips to support a wider range of young people; even to sailing round Britain twice together, Musto have evolved with us.

“To have such an enduring partnership over two decades is incredible and it will be some occasion when we celebrate 20 years in 2023. We cannot thank Musto enough for the difference they have helped to make to so many young lives over the years.” 

Nick Houchin, Head of Marketing at Musto, comments: “Having supported the Trust since 2003 and Dame Ellen in her sailing campaigns previous to this, our relationship is deep-set. We will both continue to use this as a platform to make a genuine difference for young people living through and beyond cancer.

“Many colleagues have joined trips and come back completely inspired. The emotional connection we have with the Trust makes it all worthwhile and such a fantastic cause.”

Comments are closed.